How to Inject MOTS-c: Sites, Syringes and Steps
Where to inject MOTS-c, which syringe to use, how to read units and the hygiene steps that prevent infection.
Injection sites
Most peptides are injected under the skin (subcutaneously), into the fatty layer rather than the muscle.
- Belly: at least 2 inches (5 cm) away from the navel.
- Front and outer thighs.
- Back of the upper arms, if someone else can reach it.
- Rotate sites each time and avoid skin that is bruised, scarred or irritated.
Syringe and needle
U-100 insulin syringes are marked in units: 100 units equal 1 mL, so 10 units is 0.1 mL. They come in 0.3, 0.5 and 1 mL sizes; a smaller syringe has finer marks and is easier to read for small doses. Needle length and gauge used for MOTS-c in studies: not reported in study abstracts (PubMed search, 11 Oct 2026).
How to read an insulin syringeStep by step
- 1Wash your handsUse soap and water, and work on a clean surface.
- 2Check the vialLabel, lot and date present; solution clear with no particles. Mixing a powder vial first? Use sterile bacteriostatic water.
- 3Clean the vial top and the siteWipe both with an alcohol swab and let them dry.
- 4Draw the dosePull the plunger to the units mark for your dose, then tap out air bubbles and re-check the mark.
- 5InjectPinch a fold of skin, insert the needle at 45 to 90 degrees, push the plunger slowly and wait a few seconds before withdrawing.
- 6Dispose safelyPut the used syringe straight into a sharps container. Never reuse or share needles.
No study in the cache gave MOTS-c to people; the human papers measure the body's own MOTS-c
The human exercise studies measure circulating MOTS-c as an outcome: in a randomised study of acute endurance and resistance exercise, MOTS-c showed only a trend to increase after endurance exercise.[9]
In an exercise trial in breast cancer survivors, plasma MOTS-c rose significantly from baseline and versus usual care among non-Hispanic White participants; these were the body's own levels, not an injected dose.[10]
Where MOTS-c has been injected: mouse studies, not people
In the mouse muscle-atrophy study, immobilisation cut muscle mass by about 15% in untreated mice and about 5% in mice treated with MOTS-c injections.[11]
In that mouse study the control animals were injected with sterilized water; the abstract gives the MOTS-c treatment as an injection without naming a body site.[11]
The landmark mouse paper reports that MOTS-c treatment prevented age-related and diet-induced insulin resistance and diet-induced obesity in mice; the abstract does not give route or schedule.[12]
One mouse colitis study states the route: MOTS-c was given by intraperitoneal injection, meaning into the abdominal cavity of the mouse, and reduced colitis symptoms.[13]
The same mouse study found that swallowing MOTS-c did not produce significant improvements.[13]
What the regulators say
No FDA label exists: Drugs@FDA returns no match for MOTS-c.[14]
FDA's safety-risk text says it has not identified any human exposure data on MOTS-c drug products administered by any route.[15]
FDA's advisory-committee agenda lists MOTs-C (free base and acetate) with 'Obesity and osteoporosis'.[16]
Common questions
Where do you inject MOTS-c?
The cached human papers describe no MOTS-c injection. In mice, the abstract reports daily MOTS-c injection without naming a body site.[11]
What syringe is used for MOTS-c?
Vials are usually drawn with a U-100 insulin syringe, where 100 units equal 1 mL. Common sizes hold 0.3, 0.5 or 1 mL. Match the syringe to the dose so the mark is easy to read.
How often is MOTS-c injected?
The interval comes from the study or prescription, not from this guide. See the dosage page for what studies used.
Has MOTS-c been tested as an injection in people?
Not in any study found here; the human papers measure natural MOTS-c levels after exercise or in disease.[9]
Is MOTS-c banned in sport?
Yes: MOTS-c is named in WADA's Prohibited List.[17]
More on MOTS-c
Sources
- 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
- 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
- 3PubMed search: ("MOTS-c"[tiab] OR MOTSc[tiab]) (262 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 4PubMed search: ("MOTS-c"[tiab] OR MOTSc[tiab]) AND (humans[mh] OR human[tiab] OR participants[tiab] OR patients[tiab] OR volunteers[tiab]) (179 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 5PubMed search: ("MOTS-c"[tiab] OR MOTSc[tiab]) AND (randomized controlled trial[pt] OR "clinical trial"[pt] OR "meta-analysis"[pt] OR "systematic review"[pt]) (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: ("MOTS-c"[tiab] OR MOTSc[tiab]) AND (mice[tiab] OR mouse[tiab] OR rat[tiab] OR rats[tiab]) AND (injection[tiab] OR treatment[tiab] OR administration[tiab] OR treated[tiab]) (72 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: ("MOTS-c"[tiab] OR MOTSc[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: ("MOTS-c"[tiab] OR MOTSc[tiab] OR CB4211[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (20 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 9Acute endurance exercise stimulates circulating levels of mitochondrial-derived peptides in humans.Journal of applied physiology (Bethesda, Md. : 1985) · 2021PMID 34351816Accessed 2 Oct 2026
- 10Effect of aerobic and resistance exercise on the mitochondrial peptide MOTS-c in Hispanic and Non-Hispanic White breast cancer survivors.Scientific reports · 2021PMID 34413391Accessed 2 Oct 2026
- 11Mitochondrial-derived microprotein MOTS-c attenuates immobilization-induced skeletal muscle atrophy by suppressing lipid infiltration.American journal of physiology. Endocrinology and metabolism · 2024PMID 38170165Accessed 2 Oct 2026
- 12The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.Cell metabolism · 2015PMID 25738459Accessed 2 Oct 2026
- 13Orally administered MOTS-c analogue ameliorates dextran sulfate sodium-induced colitis by inhibiting inflammation and apoptosis.European journal of pharmacology · 2023PMID 36528071Accessed 2 Oct 2026
- 14Drugs@FDA (openFDA) search: active ingredient "MOTS-c"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
- 15Official web pageOfficial web page · web page
- 16Official web pageOfficial web page · web page
- 17World Anti-Doping Code International Standard Prohibited List 2026 (in effect 1 January 2026)World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
Found an error? Report a correction.